Benjamin Duhart, Jr., M.S., Pharm.D.

Associate Professor
Department of Clinical Pharmacy and Translational Science

Office: 210 COLLEGE OF PHARMACY BUILDING
881 MADISON AVENUE
MEMPHIS TN 381632198
Tel: (901) 448-4758
btduhart@uthsc.edu

Education

  • PostDoc, University of Tennessee Health Science Center/ Bowld Hospital; Memphis, TN, Solid organ transplantation/ immunology
  • Pharm.D., University of Tennessee, Memphis, Pharmacy
  • M.S., Florida Agricultural and Mechanical University; Tallahassee, FL, Chemistry/ Bioorganic
  • B.S., Florida Agricultural and Mechanical University; Tallahassee, FL, Chemistry

Clinical Care Specialty/Interest

Solid organ transplant/ nephrology

Research Description

My research interests include Investigating factors associated with inferior outcomes of African-American kidney transplant recipients, and evaluating renal function after liver transplantation.

Research Keywords

kidney transplant recipients

African-American

renal function

Research Interest/Specialty

Solid organ transplant/ nephrology

Publications

  1. Duhart B, Snyder H, Krauss A, Apple A, Martin J, Hong S. Comparison 0f Standard and Reduced Dose Rabbit Antithymocyte Globulin Induction for Kidney Transplant Recipients with Delayed Graft Function. Journal of Pharmacovigilance and Pharmacotherapeutics, 2017 (4), 2017.
  2. Cutshall BT, Duhart BT Jr., Saikumar J, Samarin M, Hutchison L, Hudson JQ. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease. Am J Med Sci, 3 (355), 247-251, 2017.
  3. Duhart BT Jr and Self T. Concomitant Lithium and ACEIs: Increase the Index of Suspicion for Lithium Toxicity. Consultant, 57 (3), 174, 2017.
  4. Higdon EA, Kimmons LA, Duhart BT Jr, Hudson JQ. Disagreement in Estimates of Kidney Function for Drug Dosing in Obese Inpatients. J Pharm Pract, 2017.
  5. Snyder, HS, Duhart, BT, Krauss, AG, Rao, V. Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction. SAGE Open Med Case Rep, 4, 2050313X16674865, 2016.
  6. Roe, N, Twilla, JD, Duhart, B, Wheeler, B. Breast cancer patient with everolimus-induced angioedema: A rare occurrence with potential for serious consequences. J Oncol Pharm Pract, 2016.
  7. Duhart B Jr. and Self T. Proton pump inhibitor induced kidney injury: increasing our index of suspicion.. Consultant, 56 (2016), 244, 2016.
  8. Duhart, BT, Jr.. The APhA Complete Review for Pharmacy: CH 24 Solid organ transplantation., 2015.
  9. Duhart,B Jr. and Self T. Herbal-induced hepatotoxicity: increasing our index of suspicion.. Consultant, 3 (55), 202, 2015.
  10. Duhart, BT, Ally, WA, Krauss, AG, Hudson, JQ, Eason, JD, Rao, V, Vanatta, JM. The benefit of sirolimus maintenance immunosuppression and rabbit antithymocyte globulin induction in liver transplant recipients that develop acute kidney injury in the early postoperative period. J Transplant, 2015, 926168, 2014.
  11. Duhart, BT, Jr.. The APhA Complete Review for Pharmacy: CH 24 Solid organ transplantation., 2012.
  12. Patel, SJ, Knight, RJ, Suki, WN, Abdellatif, A, Duhart, BT, Krauss, AG, Mannan, S, Nezakatgoo, N, Osama Gaber, A. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age. Clin Transplant, 25 (3), E250-6, 2011.
  13. Wilson NS, Duhart BT Jr., Self T. Cephalosporins: how to minimize the risk of neurotoxicity.. Consultant Live, 50 (2), 2010.
  14. Patel, SJ, Duhart, BT, Krauss, AG, Moore, LW, Egidi, MF, Amiri, HS, Gaber, LW, Gaber, AO. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction. Transplantation, 86 (2), 313-20, 2008.
  15. Duhart, BT, Honaker, MR, Shokouh-Amiri, MH, Riely, CA, Vera, SR, Taylor, SL, Al-jedai, AH, Gaber, AO. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transpl Infect Dis, 5 (3), 126-31, 2003.
  16. Ault BH, Honaker MR, Gaber AO, Jones DP, Duhart BT, Powell SL, Hays DW, Wyatt RJ. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients.. Pediatric Nephrol, 17 (10), 815, 2002.
  17. Honaker MR, Duhart BT Jr. Tacrolimus: An update on pharmacokinetic drug interactions.. J Crit Illn, 17, 141, 2002.
  18. Duhart, BT, Zhang, D, Deck, J, Freeman, JP, Cerniglia, CE. Biotransformation of protriptyline by filamentous fungi and yeasts. Xenobiotica, 29 (7), 733-46, 1999.
  19. Zhang, D., Evans, F., Freeman, J., Duhart, Jr. BT, and Cerniglia, C.E. Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metabolism and Disposition, 23, 1417, 1995.